These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
227 related items for PubMed ID: 9311991
1. Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product. Vallone D, Battista S, Pierantoni GM, Fedele M, Casalino L, Santoro M, Viglietto G, Fusco A, Verde P. EMBO J; 1997 Sep 01; 16(17):5310-21. PubMed ID: 9311991 [Abstract] [Full Text] [Related]
2. Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo. Battista S, de Nigris F, Fedele M, Chiappetta G, Scala S, Vallone D, Pierantoni GM, Mega T, Santoro M, Viglietto G, Verde P, Fusco A. Oncogene; 1998 Jul 23; 17(3):377-85. PubMed ID: 9690519 [Abstract] [Full Text] [Related]
3. Presence of distinct AP-1 dimers in normal and transformed rat hepatocytes under basal conditions and after epidermal growth factor stimulation. Nadori F, Lardeux B, Rahmani M, Bringuier A, Durand-Schneider AM, Bernuau D. Hepatology; 1997 Dec 23; 26(6):1477-83. PubMed ID: 9397987 [Abstract] [Full Text] [Related]
4. Fra-1 promotes growth and survival in RAS-transformed thyroid cells by controlling cyclin A transcription. Casalino L, Bakiri L, Talotta F, Weitzman JB, Fusco A, Yaniv M, Verde P. EMBO J; 2007 Apr 04; 26(7):1878-90. PubMed ID: 17347653 [Abstract] [Full Text] [Related]
5. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model. Zoumpourlis V, Papassava P, Linardopoulos S, Gillespie D, Balmain A, Pintzas A. Oncogene; 2000 Aug 17; 19(35):4011-21. PubMed ID: 10962557 [Abstract] [Full Text] [Related]
6. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes. Li JJ, Rhim JS, Schlegel R, Vousden KH, Colburn NH. Oncogene; 1998 May 28; 16(21):2711-21. PubMed ID: 9652737 [Abstract] [Full Text] [Related]
8. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness. Giannini G, Di Marcotullio L, Ristori E, Zani M, Crescenzi M, Scarpa S, Piaggio G, Vacca A, Peverali FA, Diana F, Screpanti I, Frati L, Gulino A. Cancer Res; 1999 May 15; 59(10):2484-92. PubMed ID: 10344762 [Abstract] [Full Text] [Related]
9. Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation. Yang HS, Knies JL, Stark C, Colburn NH. Oncogene; 2003 Jun 12; 22(24):3712-20. PubMed ID: 12802278 [Abstract] [Full Text] [Related]
10. Thyroid cell transformation requires the expression of the HMGA1 proteins. Berlingieri MT, Pierantoni GM, Giancotti V, Santoro M, Fusco A. Oncogene; 2002 May 02; 21(19):2971-80. PubMed ID: 12082527 [Abstract] [Full Text] [Related]
11. Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun- or fos-induced fibroblast transformation. Hartl M, Bister K. Oncogene; 1998 Dec 03; 17(22):2901-13. PubMed ID: 9879996 [Abstract] [Full Text] [Related]
12. Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-alpha mediated repression of viral transcription and modification of the AP-1 transcription complex. Soto U, Das BC, Lengert M, Finzer P, zur Hausen H, Rösl F. Oncogene; 1999 May 27; 18(21):3187-98. PubMed ID: 10359524 [Abstract] [Full Text] [Related]
13. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers. Suzukawa K, Colburn NH. Oncogene; 2002 Mar 28; 21(14):2181-90. PubMed ID: 11948401 [Abstract] [Full Text] [Related]
14. Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins. Risse-Hackl G, Adamkiewicz J, Wimmel A, Schuermann M. Oncogene; 1998 Jun 11; 16(23):3057-68. PubMed ID: 9662339 [Abstract] [Full Text] [Related]
15. Expression and distribution of AP-1 transcription factors in the porcine ovary. Rusovici R, LaVoie HA. Biol Reprod; 2003 Jul 11; 69(1):64-74. PubMed ID: 12606371 [Abstract] [Full Text] [Related]
16. Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins. Miller C, Zhang M, He Y, Zhao J, Pelletier JP, Martel-Pelletier J, Di Battista JA. J Cell Biochem; 1998 Jun 15; 69(4):392-413. PubMed ID: 9620167 [Abstract] [Full Text] [Related]
17. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer. Zerbini LF, Wang Y, Cho JY, Libermann TA. Cancer Res; 2003 May 01; 63(9):2206-15. PubMed ID: 12727841 [Abstract] [Full Text] [Related]
18. Fos-related antigen 1 modulates malignant features of glioma cells. Debinski W, Gibo DM. Mol Cancer Res; 2005 Apr 01; 3(4):237-49. PubMed ID: 15831677 [Abstract] [Full Text] [Related]
19. Human T-cell leukemia virus type 1 tax protein activates transcription through AP-1 site by inducing DNA binding activity in T cells. Iwai K, Mori N, Oie M, Yamamoto N, Fujii M. Virology; 2001 Jan 05; 279(1):38-46. PubMed ID: 11145887 [Abstract] [Full Text] [Related]
20. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells. Kutz SM, Providence KM, Higgins PJ. Cell Motil Cytoskeleton; 2001 Mar 05; 48(3):163-74. PubMed ID: 11223948 [Abstract] [Full Text] [Related] Page: [Next] [New Search]